I still feel like the situation with A40 is an 'either or' one. Merge and focus the company on spodumene production with a GXY purchase of a converter or develop SDV.
As for @asb83 the situation with SDV will become clearer over the next six months in my opinion. The cash on hand is more than sufficient to progress development of SDV past significant derisking milestones - ie operational pilot plant. You also tend to ignore the significant funds that have already been spent on development or future operating profits from Mt Cattlin that can be used to partially fund development.
Given the cash on hand, GXY can progress SDV at full pace and still have 18 months to organize financing through a combination of debt and equity.
It is my belief that GXY has not had the expertise at the top to progress SDV on its own. The new CEO appears to have the resume to back up his tasking of bringing SDV into production.
AIMHO
- Forums
- ASX - By Stock
- GXY
- Tipping Competition
Tipping Competition, page-292
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add GXY (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LGP
LITTLE GREEN PHARMA LTD
Paul Long, CEO
Paul Long
CEO
Previous Video
Next Video
SPONSORED BY The Market Online